Skip to content

Short Term Outcomes of Robotic-assisted Intersphincteric Resection for Low Rectal Cancer

Short Term Outcomes of Robotic-assisted Intersphincteric Resection for Low Rectal Cancer:A Multicentric Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03597126
Acronym
R-ISR
Enrollment
100
Registered
2018-07-24
Start date
2018-12-01
Completion date
2022-12-01
Last updated
2021-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Cancer

Keywords

Robotic, Intersphincteric Resection, rectal cancer, pelvic autonomic nerve anal function

Brief summary

This study compared robot-assisted total mesorectal excision to treat very low rectal cancer within 2 cm from the dentate line to avoid permanent colostomy. improves the quality of life with better defecation function, urinary function and sexual function.

Interventions

robot-assisted intersphincteric resection for low location rectal cancer(T=1&2)

DEVICELaparoscopic surgery

laparoscopic intersphincteric resection for low location rectal cancer(T=1&2)

Sponsors

Southwest Hospital, China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. 18 years \< age \< 80 years 2. Matching the diagnostic criteria; 3. tumor located 3 cm from anal verge 4. Clinically diagnosed cT1-3N0-2 M0 lesions 5. Tumor size of 4 cm or less 6. ASA 1-3 scores; 7. ECOG score is 0-1; 8. Adequate preoperative sphincter function

Exclusion criteria

1. Requiring a Mile's procedure 2. Fecal incontinence; 3. Previous abdominal surgery 4. Severe mental disease. 5. Intolerance of surgery for severe comorbidities 6. Emergency operation due to complication 7. Pregnant woman or lactating woman

Design outcomes

Primary

MeasureTime frameDescription
Change in Female Sexual Function Index [FSFI]18 monthsAlterations in FSFI from baseline up to 18 months postoperatively - 19-item self-report measure, each item ranges from 0-5, with full range from 2 to 36, with low score indicating sexual function disorder.
Change in urinary function6 monthsThe days of indwelling catheter after operation The overall efficiency of urination function
Change in International Index of Erectile Function [IIEF] score18 monthsAlterations in IIEF scores from baseline up to 18 months postoperatively - 15 item questionnaire, each item range from 0 - 5, with total score to 30. lower score indicates more severe erectile dysfunction (ED)
Change in FIQL scores18 monthsAlterations in Fecal Incontinence Quality of Life Instrument (FIQL) scores from baseline up to 18 months postoperatively - 29 items range from 1 (strongly agree) to 4 (strongly disagree); with a 1 indicating a lower functional status of quality of life. Scale scores are only calculated if at least half of the items have been answered

Countries

China

Contacts

Primary ContactTang Bo, M.D
yupeiwu1961@aliyun.com+86 13883902288
Backup ContactLi Chuan, M.D
lee_tran@126.com+86-18323479228

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026